Northwestern University Trials Behavioral Treatments for Narcolepsy-Related Nightmares
A clinical trial is underway to evaluate the effectiveness of imagery rehearsal therapy and targeted dream control for treating nightmares in narcolepsy patients.
Phase III
Neurology / Narcolepsy
Status
Active
Signal Score
6.8
Signal assessment
Signal strength
moderate
Confidence level
moderate
Why it matters
This clinical trial explores non-pharmacological treatments for narcolepsy-related nightmares, which could shift current treatment paradigms. Successful outcomes may lead to new management strategies, impacting existing therapies and market dynamics.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results and participant feedback on treatment efficacy and safety over the next 13 weeks.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.